Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9596 posts found.

FDA approves Eisai-Biogen’s lecanemab for Alzheimer’s disease

January 9, 2023 Research and Development

The FDA has approved Eisai and Biogen’s experimental antibody treatment lecanemab (also known as Leqembi) for the treatment of mild …
News

Island Pharmaceuticals to begin phase 2 trial for dengue prevention and treatment drug

January 5, 2023 Research and Development

It is possible that Island Pharmaceuticals could begin its phase 2a PEACH clinical trial as soon as January 2023. The …
News

Belharra Therapeutics and Genentech join forces for small molecule medicine development

January 5, 2023 Research and Development

US-based biotech companies Belharra Therapeutics and Genentech have announced a multi-year partnership to lead the discovery and development of small …
News

Biogen and Alcyone Therapeutics enter partnership to develop ThecaFlex DRx system for ASO therapies

January 5, 2023 Research and Development

US-based Biogen and Alcyone Therapeutics have entered into a license and collaboration agreement to develop Alcyone’s ThecaFlex DRx™ System.   …
News

Rare cancer drug for young patients approved

January 3, 2023 Research and Development

A new treatment option for adult and paediatric patients with a rare soft tissue cancer has been approved. The FDA …
News

Abiomed receives FDA approval for heart pump clinical trial

December 22, 2022 Research and Development

Abiomed, a leading provider of medical technology focusing on the circulatory system and oxygenation, has announced that the FDA has …
News

Idorsia submits new drug application to FDA for aprocitentan to treat difficult-to-control hypertension

December 20, 2022 Research and Development

Idorsia has announced that it has submitted a new drug application (NDA) to the FDA in hopes of gaining approval …
News

AlzeCure has abstract accepted on possible disease-modifying effects of ACD856 against Alzheimer’s

December 20, 2022 Research and Development

AlzeCure, a pharma company who focuses on its portfolio of small molecule candidate drugs for central nervous system (CNS) diseases, …
News

New study shares effectiveness of asthma drug compared to standard of care

December 19, 2022 Research and Development

The University of Plymouth has co-authored a new study, published in The Lancet, which shows how an asthma drug, commercially …
News

Targeted imaging agent for lung cancer surgery approved by FDA

December 19, 2022 Research and Development

The FDA has approved Cytalux (pafolacianine) to be used in lung cancer surgery: the targeted imaging agent binds to cancerous …
News

CDC provides $12.5m grant to study real-world effectiveness of vaccines

December 16, 2022 Research and Development

The Center for Disease Control and Prevention (CDC) has given researchers at Washington University School of Medicine in St Louis, …
News

New blood test appears to detect hidden cancer

December 16, 2022 Research and Development

Biotech company Guardant Health has announced that its blood test-based cancer screening technique appears to be effective: the liquid biopsy …
News

Merck and Moderna’s mRNA cancer vaccine is successful in efficacy trial

December 14, 2022 Research and Development

Merck & Co and Moderna have partnered to utilise the mRNA technology used to combat COVID-19, however this time the …
News

ClearPoint recruits first patient in laser therapy study to treat Glioblastoma

December 14, 2022 Research and Development

California, US-based ClearPoint Neuro has recruited the first patient in a clinical trial which will use ClearPoint’s Prism Neuro Laser …
News

AI model predicts CVD risk from single chest radiograph

December 14, 2022 Research and Development

A recently-developed AI model has been shown to predict ten-year incidences with a similar level of success to the current …
News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026